Beam stock forecast.

Beam Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030. In the last three years, Beam Therapeutics's EPS has grown, increasing from $-2.49 to $-4.13 – an increase of 65.86%. For the next year, 13 analysts project Beam Therapeutics's EPS to drop by 3.39%, reaching $-3.99. By 2030, professionals believe that Beam Therapeutics's ... The Fly Beam Therapeutics price target lowered to $26 from $35 at Barclays. 21d ago. Press Releases Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results. 22d ago. Press Releases Beam Therapeutics to Participate in 2023 Jefferies London Healthcare Conference. 22d ago.Average 51.83 75.87% Upside Low 19.00 -35.53% Downside High 95.00 222.36% Upside Broker Rating Beam Therapeutics Inc. currently has an average brokerage recommendation (ABR) of 1.86 on a scale of... October 30, 2023 at 7:00 AM · 5 min read. Wall Street expects a year-over-year increase in earnings on lower revenues when Beam Therapeutics Inc. (BEAM) reports results for the quarter ended ...

Inflation and geopolitical conflicts remain risks for investors. The stock market is entering the end of 2023 with major positive momentum, including an eight-day winning streak for the S&P 500 in ...Here are two such stocks that could generate monstrous returns on capital over the long run. Image source: Getty Images. 1. Beam Therapeutics. Beam Therapeutics ( BEAM -1.72%) is a biotechnology ...BEAM stock, belonging to Beam Therapeutics Inc, has shown promising performance on August 29, 2023, according to data from CNN Money. The 15 analysts offering 12-month price forecasts for BEAM stock have a median target of $56.00, with a high estimate of $105.00 and a low estimate of $32.00.

Find real-time NIO - NIO Inc stock quotes, company profile, news and forecasts from CNN Business.See the latest Beam Therapeutics Inc stock price (BEAM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Beam Therapeutics Inc. Watch NEW Set a price target alert After Hours Last Updated: Nov 28, 2023 4:20 p.m. EST Delayed quote $ 29.77 0.00 0.00% After Hours Volume: 14.9K Advanced Charting Volume:...$-4.18 Market Cap $2.02 B Shares Outstanding 81.50 M Public Float 68.49 M Yield BEAM is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend …TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comKey Points. Cathie Wood is an icon in the world of disruptive tech. Her firm ARK Invest holds positions in Beam Therapeutics, COMPASS Pathways, and 908 Devices. Wall Street analysts have ...

BEKE one year forecast. KE Holdings stock monthly and weekly forecasts. Skip to content. FORECST.COM 2023 – 2026 Stock Market Forecast BEKE stock forecast for 2023 – 2027. Last updated: October 26, 2023. Are you interested in KE Holdings Inc. stocks prediction? ... BEAM Stock Forecast; BE Stock Forecast;

According to the issued ratings of 11 analysts in the last year, the consensus rating for Beam Therapeutics stock is Hold based on the current 6 hold ratings and 5 buy ratings for BEAM. The average twelve-month price prediction for Beam Therapeutics is $48.80 with a high price target of $105.00 and a low price target of $20.00. Learn more on ...

According to 4 analyst offering 12-month price targets in the last 3 months, Beam Therapeutics has an average price target of $70.25 with a high of $105.00 and a low of $37.00. Below is a summary ...Beam Global has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 3rd, 2024 based off last year's report dates. Learn more on BEEM's earnings history.Global whiskey market: leading brands based on sales volume 2022. In 2022, some 30.8 million 9 liter cases of McDowell's No. 1 whiskey were sold worldwide. Royal Stag was number two that year ...Lead the world to clean mobility. We believe every person deserves access to safe, clean, reliable transportation. BEAM’s 100% sustainable EV charging solutions are the most rapidly deployed EV charging stations in the world. Fastest Deployed EV Charging In Action.BEEM Stock 12 Months Forecast. $24.00. (228.09% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Beam Global in the last 3 months. The average price target is $24.00 with a high forecast of $40.00 and a low forecast of $12.00. The average price target represents a 228.09% change from the last price of $7.32. Open the BEAM Page at The Online Investor (in a new window) » List of Beverages & Wineries Mergers & Acquisitions in this Slideshow:. 10/3/2012: Acquirer: Crystal Rock Holdings, Inc. (CRVP) Acquiree: Frontenac Crystal Springs and Girard Water Company Merger/Acquisition details: details » 12/14/2012: Acquirer: Coca-Cola FEMSA (KOF) …

Mar 21, 2023 · According to 4 analyst offering 12-month price targets in the last 3 months, Beam Therapeutics has an average price target of $70.25 with a high of $105.00 and a low of $37.00. Below is a summary ... Scores. BEAM has an Altman Z-Score of 1.39 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. 1.39. Piotroski F-Score. 2. Detailed statistics for Beam Therapeutics Inc. (BEAM) stock, including valuation metrics, financial numbers, share information and more.There are four main types of forecasting methods that financial analysts use to predict future revenues, expenses, and capital costs for a business. While there are a wide range of frequently used quantitative budget forecasting tools, in this article we focus on four main methods: (1) straight-line, (2) moving average, (3) simple linear ...Dec 1, 2023 · A high-level overview of Beam Therapeutics Inc. (BEAM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Fiscal Q3 2023 ended 9/30/23. Get the latest Beam Therapeutics Inc (BEAM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading...Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -8.44M. -19.71%. Get the latest Beam Global (BEEM) real-time quote ...

3 Wall Street research analysts have issued 12-month price targets for Beam Global's shares. Their BEEM share price targets range from $25.00 to $25.00. On average, they anticipate the company's stock price to reach $25.00 in the next year. This suggests a possible upside of 315.3% from the stock's current price.

Beam Therapeutics ( BEAM 0.68%) recently signed a major research deal with Pfizer ( PFE 0.59%) that could be worth up to $1.35 billion, and hardly anyone seemed to notice. This was clearly great ...Find the latest Ion Beam Applications SA (IBAB.BR) stock quote, history, news and other vital information to help you with your stock trading and investing.Adaptive Biotechnologies (ADPT) Stock Forecast & Price TargetTomorrow's movement Prediction of Infibeam Incorp. INFIBEAM appears to be in uptrend. And this trend seems to be continuing further. Price is above an important level of 20.84 on charts, and as long as price remains …Find real-time DNA - Ginkgo Bioworks Holdings Inc stock quotes, company profile, ... EPS forecast (this quarter)-$0.07: Annual revenue (last year) $477.7M: Annual profit (last year)Apple Inc () Stock Market info Recommendations: Buy or sell Apple stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Apple share forecasts, stock quote and buy / sell signals below.According to present data Apple's AAPL shares and potentially its market environment have been in a bullish cycle in the last 12 …Future criteria checks 2/6. CRISPR Therapeutics is forecast to grow earnings and revenue by 46.4% and 48.2% per annum respectively. EPS is expected to grow by 45.6% per annum. Return on equity is forecast to be 2% in 3 years.Term Box: Best Beam forecast, Beam price prediction, Beam coin forecast, Beam finance tips, Beam cryptocurrency prediction, BEAM analyst report, Beam price predictions 2023, BEAM currency forecast, Beam forecast tomorrow, Beam technical analysis, Beam coin future price, BEAM projections, Beam market prognosis, Beam expected price.

Find the latest Roku, Inc. (ROKU) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid Term ...

Find the latest Beam Global (BEEM) stock quote, history, news and other vital information to help you with your stock trading and investing.

Wall Street Stock Market & Finance report, prediction for the future: You'll find the Beam Global share forecasts, stock quote and buy / sell signals below. According to present data Beam Global's BEEM shares and potentially its market environment have been in bearish cycle last 12 months (if exists). (See Tritium stock forecast on TipRanks) Beam Global . Beam Global, the second EV charging stock we’re looking at, provides a range of power products for use in a variety of charging and battery ...Beam Therapeutics Inc Stock Price History. Beam Therapeutics Inc’s price is currently down 1.73% so far this month. During the month of April, Beam Therapeutics Inc’s stock price has reached a high of $32.82 and a low of $28.62. Over the last year, Beam Therapeutics Inc has hit prices as high as $73.27 and as low as $27.77. Year to date ...(NASDAQ: SGMO) Sangamo Therapeutics's forecast annual revenue growth rate of -28.5% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.06%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.51%.For Beam Global stock forecast for 2023, 1 predictions are offered for each month of 2023 with average Beam Global stock forecast of $6.11, a high forecast of $6.11, and a low forecast of $6.11. The average Beam Global stock forecast 2023 represents a 4.43% increase from the last price of $5.84999990463257. For Beam Global stock forecast for ...Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing ...Beam Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030. In the last three years, Beam Therapeutics's EPS has grown, increasing from $-2.49 to $-4.13 – an …Stock Price Forecast The 12 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 10.50, with a high estimate of 19.00 and a low estimate of ...Beam Therapeutics, a leading biotechnology company specializing in the development of precision genetic medicines through base editing, has recently announced a strategic restructuring and portfolio prioritization.This move aims to emphasize potential drivers of immediate value and long-term growth within their pipeline. With a strong focus …Beam Therapeutics Inc. 27.50. Delayed Data. As of Nov 17. +2.71 / +10.93%. Today’s Change. 16.95. Today ||| 52-Week Range. 51.60.

January has now been and gone and turned out to be a nice gift for investors. Battered by 2022’s bear, the tech-heavy Nasdaq, in particular, put in an excellent showing, seeing out the month ~11 ...Find the latest Flex Ltd. (FLEX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid Term ...Beam Therapeutics Inc. 27.50. Delayed Data. As of Nov 17. +2.71 / +10.93%. Today’s Change. 16.95. Today ||| 52-Week Range. 51.60. Find real-time NIO - NIO Inc stock quotes, company profile, news and forecasts from CNN Business.Instagram:https://instagram. macquarie group limited stockchatgpt share pricefidelity paper trading accountmortgage companies nyc Average 51.83 75.87% Upside Low 19.00 -35.53% Downside High 95.00 222.36% Upside Broker Rating Beam Therapeutics Inc. currently has an average brokerage recommendation (ABR) of 1.86 on a scale of... highest paying prop trading firmsnat stock forecast NTLA Stock 12 Months Forecast. Based on 19 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $78.65 with a high forecast of $136.00 and a low forecast of $31.00. The average price target represents a 151.68% change from the last price of $31.25. intuitive surgical inc stock View the latest Beam Therapeutics Inc. (BEAM) stock price, news, historical charts, analyst ratings and financial information from WSJ. Tritium shares are priced at $6.34 and their average price target of $14.40 implies an upside potential of ~127%. ( See Tritium stock forecast on TipRanks) Beam Global, the second EV charging ...